LXS.DE: a 2028 sale it can force
Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.
Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.
$ARKK is an excellent alternative hedge short IMO to QQQ. A bit of timing to avoid the massive bubbles but way more follow through to the downside. https://t.co/jyUYhlMit4
$ARKK vs $SPY vs $QQQ by year. https://t.co/XEaaaCTQvL
@Menckenist @rippercatcher Very interesting. What's the typical mix of a $WD loan? Is it moslty fixed rate with 5-7 year maturity? How much of it is the type that finance the S2 and Tide capital where deals were done at 3% cap with floating rate debt greatly appreciate this!
Silgan to Combine With Trivium Packaging in $3.4 Billion Deal $SLGN https://t.co/XWQSkZuUO5
Germany’s Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion $SLN https://t.co/FXr0mtRMow
H.B. Fuller Rejects Ancora’s Latest Acquisition Bid, Plans to Consider Selling Noncore Businesses $FUL https://t.co/L8b85qb666
Avis Wipeout Erases Last Vestige of 600% Short Squeeze Rally $CAR https://t.co/5YhPTjmIi0
LendingTree derives roughly two-thirds of revenue from insurance and trades near 4 times expected adjusted earnings despite record revenue,…
Occidental Petroleum’s debt should fall further after Q3 oil prices averaged $85 per barrel WTI and $91 Brent.
Elutia’s antibiotic-eluting surgical matrices target breast-surgery infections, with Minot Light valuing $100 million in sales at a…
Hess Midstream, Iovance Biotherapeutics, Netlist and nine other lesser-covered stocks make this week’s Undercovered Dozen.
SiriusXM trades at 6.5 times free cash flow, a 15% yield, with high short interest and catalysts that could drive a short squeeze.
Gloo's $3.25 follow-on, going-concern warning and $28.0 million first-half cash burn frame the short case against its acquisition-driven…
Tower Properties, $TPRP, went dark after a 2006 squeeze-out cut holders below 300, leaving a Kemper-controlled apartment and office…
Bumble agreed to a $1.3 billion take-private deal, while Netflix cut about 1,000 jobs and Meta discussed its Muse superintelligence models.
Dorchester Minerals' 9.5% normalized yield and debt-free royalty model are offset by limited upside at $29.71, as extraordinary…
FULC · long Fulcrum Therapeutics trades below cash as it pursues a likely reverse merger, creating a biotech shell opportunity.
Howard Hughes plans to raise nearly $4 billion by selling real estate assets and condos, accelerating Vantage’s insurance expansion while…
EVI Industries says its ERP and service-platform build is largely complete, testing whether 10.8% revenue growth can finally outpace…
Lennar is selling homes to former spinoff Millrose, whose revenue largely comes from Lennar and whose largest voting shareholder is…
Huckleberry.AI trades near $3.30 against $221 million of cash and $900 million-plus of NOLs after selling its operating business, creating…
Rocket Lab reported Q2 revenue up 62% to $234.1 million and backlog up 137% to $2.36 billion, while operating losses and cash burn…
AAR’s $1.8 billion acquisition of a 65% stake in MRO Holdings adds widebody aircraft maintenance and targets a 19% to 20% EBITDA margin by…
The Trade Desk's Q2 revenue grew 3% to $715 million as Q3 guidance called for a year-over-year decline; TTD has fallen over 90% from its…
Belden targets net leverage of 2.9x by 2027 from 3.9x, using RUCKUS's 65%+ gross margins and free cash flow to reduce debt.
Crocs has $2 billion of buyback authorization, more than a third of its market cap, as North American sales stabilize and HeyDude drags on…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.